Finance

Beta
Lists
VENUSREM:NSE
Venus Remedies Ltd
₹1,633.50
+4.99%
(+77.70) 1D
Jun 5, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for VENUSREM...
Open
₹1,593.80
High
₹1,633.50
Low
₹1,559.70
Mkt. cap
21.83B
Avg. vol.
72.31K
Volume
177.14K
Dividend
0.61%
Quarterly dividend
₹2.50
Ex-dividend date
Aug 7, 2026
P/E ratio
21.24
52-wk high
₹1,633.50
52-wk low
₹415.40
EPS
₹76.89
Shares outstanding
12.34M
No. of employees
1K
Open
₹1,593.80
High
₹1,633.50
Low
₹1,559.70
Mkt. cap
21.83B
Avg. vol.
72.31K
Volume
177.14K
Dividend
0.61%
Quarterly dividend
₹2.50
Ex-dividend date
Aug 7, 2026
P/E ratio
21.24
52-wk high
₹1,633.50
52-wk low
₹415.40
EPS
₹76.89
Shares outstanding
12.34M
No. of employees
1K
News stories
From sources across the web
About Venus Remedies Ltd
CEOSaransh Chaudhary
Employees1.3K
Founded1989
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.32B
1.93B
1.80B
2.59B
Cost of goods sold
741.50M
1.07B
862.50M
1.20B
Cost of revenue
741.50M
1.07B
862.50M
1.20B
Research and development expenses
39.90M
43.50M
47.30M
51.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
436.60M
501.30M
517.60M
713.20M
Operating expense
538.30M
606.50M
630.50M
831.80M
Total operating expenses
1.28B
1.68B
1.49B
2.03B
Operating income
39.20M
247.90M
309.60M
566.60M
Other non operating income
87.00M
17.10M
25.20M
49.50M
EBT including unusual items
126.10M
264.90M
334.70M
616.00M
EBT excluding unusual items
126.10M
264.90M
334.70M
616.00M
Income tax expense
30.10M
63.60M
78.90M
141.10M
Effective tax rate
23.87%
24.01%
23.57%
22.91%
Other operating expenses
-
-
-
-
Net income
96.00M
201.30M
255.80M
474.90M
Net profit margin
7.28%
10.44%
14.19%
18.31%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-100.00K
-100.00K
-100.00K
-100.00K
Net interest expenses
-100.00K
-100.00K
-100.00K
-100.00K
Depreciation and amortization charges
61.80M
61.70M
65.60M
67.60M
EBITDA
88.19M
309.65M
358.59M
630.78M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more